Ocumetics Technology Corp. confirmed the successful completion of its biocompatibility animal study, in preparation for its first-in-human study, anticipated to commence in first quarter of 2024 in the Dominican Republic. The biocompatibility of the Ocumetics accommodating intraocular lens (the "Ocumetics Accommodating Lens") was evaluated by surgical implantation of two lenses into the eyes of rabbits.

The first lens, the Ocumetics Accommodating Lens, was compared to the second lens, a commercially available monofocal intraocular lens ("IOL") as a control. Results from this three-month animal study demonstrated that there were no biocompatibility or safety issues related to the Ocumetics Accommodating Lens when compared to the control IOL. The study also evaluated the occurrence of anterior and posterior capsular opacification in the rabbit model over the three month period.

There were no significant differences between the two IOL groups in terms of posterior capsular opacification and anterior capsular opacification at the end of the study.